Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Clinical trial NCT00509899 · COMPLETED

Trial details

NCT number: NCT00509899
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Polycythemia Vera Thrombocytosis

Start date: 2007-06-01
Primary completion: 2007-12-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.